Cambridge Heart company logo

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

cambridgeheart.com

Founded Year

1990

Stage

PIPE | IPO

Total Raised

$11.58M

About Cambridge Heart

Cambridge Heart is a Healthcare/Medical Devices & Equipment company based in Tewksbury, Massachusetts. Cambridge Heart's investors include Bristol Capital Advisors, Alpha Capital Partners, Balestra Capital, SF Capital Partners, Bluegrass Growth Fund Partners, Tail Wind Fund, SDS Capital Partners and ProMed Capital.

Cambridge Heart Headquarter Location

100 Ames Pond Drive Suite 100

Tewksbury, Massachusetts, 01876,

United States

978-654-7600

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest Cambridge Heart News

Cambridge Heart and Lung Research Institute receives major funding boost

Jul 11, 2019

11-07-2019 Chris Skidmore, Minister for Universities, Science, Research and Innovation, has announced a £30 million award to the University of Cambridge to support the new Cambridge Heart and Lung Research Institute (HLRI). The Institute will draw together the highest concentration of heart and lung researchers from academia, healthcare and industry in Europe. It has set an ambitious five year target to demonstrate proof-of-concept for at least ten new drugs or diagnostic approaches in heart and lung diseases. The HLRI will be situated next to Royal Papworth Hospital, which was officially opened by HM the Queen yesterday, and forms part of the Cambridge Biomedical Campus, the centrepiece of the largest biotech cluster outside the United States. It will be home to over 380 scientists and state-of-the-art laboratories in genomics, population sciences, research into cellular mechanisms of disease and translational science. It will also include a special ten bed facility where the first-in-patient studies of new treatments can be conducted. “This is an incredibly exciting project bringing together world-renowned expertise in cardiovascular and respiratory science at Cambridge University and clinical excellence at Royal Papworth Hospital,” says Professor Nick Morrell from the University of Cambridge, Interim Director of the institute and a non-Executive Director of Royal Papworth Hospital. “Heart and lung diseases affect many millions of people of people worldwide and the numbers are growing. Institutes such as ours, focussed on these big health challenges, are urgently needed. The discoveries made by our researchers will deliver major benefits to the public through improvements in public health, new approaches to diagnosing and treating disease, and new medicines.” Professor John Wallwork, Chairman of Royal Papworth Hospital, said: “The Heart and Lung Research Institute will mean new treatments will be created, tested and delivered to tackle the biggest causes of premature death in the world all on one site. This will be a huge step forward and demonstrates one of the reasons Royal Papworth Hospital moved to the Cambridge Biomedical Campus – to collaborate with the best researchers in the world to help to save lives. The importance of this building cannot be underestimated and I can’t wait to see how it will transform healthcare in the years to come.” The award is one of 11 announced from flagship capital investment scheme the UK Research Partnership Investment Fund, totalling over £670m of new investment into UK research and innovation. It complements £10 million of funding committed to the institute by the British Heart Foundation (BHF). Further funding will be provided by the University and Royal Papworth Hospital, and the Wolfson Foundation.

  • When was Cambridge Heart founded?

    Cambridge Heart was founded in 1990.

  • Where is Cambridge Heart's headquarters?

    Cambridge Heart's headquarters is located at 100 Ames Pond Drive, Tewksbury.

  • What is Cambridge Heart's latest funding round?

    Cambridge Heart's latest funding round is PIPE.

  • How much did Cambridge Heart raise?

    Cambridge Heart raised a total of $11.58M.

  • Who are the investors of Cambridge Heart?

    Investors of Cambridge Heart include ProMed Capital, Balestra Capital, Tail Wind Fund, Alpha Capital Partners, SDS Capital Partners and 9 more.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.